Guanine Inc
Guanine Inc. is revolutionizing the field of biodetection by providing rapid multiplex quantification of low concentration biological materials, enabling the diagnosis of complex illnesses and prevention of outbreaks. Their patented electrochemical oligonucleotide detection tags facilitate inexpensive and efficient testing for a wide range of microorganisms, including drug-resistant strains and viruses. The company’s innovative approach integrates AI for enhanced diagnostics, making it a key player in the healthcare AI market, which is projected to grow significantly. With a focus on precision medicine and industrial microbiology, Guanine's products are adaptable for various lucrative applications, positioning them strongly in the market.
Guanine Inc
Guanine Inc. is revolutionizing the field of biodetection by providing rapid multiplex quantification of low concentration biological materials, enabling the diagnosis of complex illnesses and prevention of outbreaks. Their patented electrochemical oligonucleotide detection tags facilitate inexpensive and efficient testing for a wide range of microorganisms, including drug-resistant strains and viruses. The company’s innovative approach integrates AI for enhanced diagnostics, making it a key player in the healthcare AI market, which is projected to grow significantly. With a focus on precision medicine and industrial microbiology, Guanine's products are adaptable for various lucrative applications, positioning them strongly in the market.
TL;DR
Sector: Biotechnology — diagnostics (electrochemical biosensing)
Founded: 2013
Headquarters: Rensselaer, New York
Distinctive tech: Software-defined electrochemical sensing (eOligo platform)
Recent disclosed funding: Seed round (May 19, 2022)
Company Overview
Problem Domain
Rapid, low-cost multi-omic detection and functional phenotyping for clinical diagnostics (including sepsis and antimicrobial resistance) and industrial microbiology.
Founded
2013
Industry
Biotechnology
Tech Stack
Funding Track Record
Seed round disclosed on May 19, 2022; Crunchbase lists Newchip Accelerator as an investor/participant. Total funding summarized in profile as $250,000.